Immunohistochemical Expression of CD68, P53 and Bcl2 in Thyroid Tumors
Keywords:Thyroid tumors, Immunohistochemistry, CD68, P53, Bcl2
Background/aim: The aim of this study was to determine the expression of CD68, P53 and Bcl2 in thyroid tumors and correlation between them.
Materials and Method: The expression of CD68, P53 and Bcl2 was examined by immunohistochemistry on paraffin-embedded tissues obtained from patients with benign and malignant tumors between 2010 and 2015.Thirty three malignant thyroid tumors of variable subtypes and 10 benign tumors. The extents of staining and intensity were scored semi quantitatively.
Results: CD68 have shown strong positive score expression in (28.9%) in PTC while score was found in (18.5%). The higher percentage of strong weak positive score expression of P53 was in PTC (6.1%) Followed by (3.03%) strong score in FTC, (3.03%) moderate score in benign and (3.03%) in MTC. The expression of Bcl2 was higher in benign tumors (20%) than in malignant tumors were PTC (9.1%) followed by FTC (3.03%), the strong positive expression seen in MTC (9.1).
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details
This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions